FBX

ethyl N-[2-azanyl-4-[(4-fluorophenyl)methylamino]phenyl]carbamate

Created:2020-04-27
Last modified:  2020-11-05

Find related ligands:

Chemical Details

Formal Charge0
Atom Count40
Chiral Atom Count0
Bond Count41
Aromatic Bond Count12
2D diagram of FBX

Chemical Component Summary

Nameethyl N-[2-azanyl-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
SynonymsRetigabine; Ezogabine
Systematic Name (OpenEye OEToolkits)ethyl ~{N}-[2-azanyl-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
FormulaC16 H18 F N3 O2
Molecular Weight303.331
TypeNON-POLYMER

Chemical Descriptors

TypeProgramVersionDescriptor
SMILESCACTVS3.385CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N
SMILESOpenEye OEToolkits2.0.7CCOC(=O)Nc1ccc(cc1N)NCc2ccc(cc2)F
Canonical SMILESCACTVS3.385 CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)cc1N
Canonical SMILESOpenEye OEToolkits2.0.7 CCOC(=O)Nc1ccc(cc1N)NCc2ccc(cc2)F
InChIInChI1.03 InChI=1S/C16H18FN3O2/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11/h3-9,19H,2,10,18H2,1H3,(H,20,21)
InChIKeyInChI1.03 PCOBBVZJEWWZFR-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB04953 
NameEzogabine
Groups
  • approved
  • investigational
DescriptionEzogabine (D23129) is a close structural analog of the centrally acting analgesic flupitrine. It is a neuronal potassium channel opener being developed as a first-in-class antiepileptic drug (AED) and is currently being studied in Phase 3 trials as an adjunctive treatment for partial-onset seizures in adult patients with refractory epilepsy. FDA approved in June 10, 2011 under the name of ezogabine.
Synonyms
  • Retigabina
  • Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate
  • N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester
  • Ezogabine
  • EZG
Brand Names
  • Potiga
  • Trobalt
IndicationAdjuvant treatment of partial-onset seizures.
Categories
  • Acids, Acyclic
  • Amines
  • Aniline Compounds
  • Anticonvulsants
  • Central Nervous System Agents
ATC-CodeN03AX21
CAS number150812-12-7

Drug Targets

NameTarget SequencePharmacological ActionActions
Potassium voltage-gated channel subfamily KQT member 3MGLKARRAAGAAGGGGDGGGGGGGAANPAGGDAAAAGDEERKVGLAPGDV...unknownmodulator
Potassium voltage-gated channel subfamily KQT member 2MVQKSRNGGVYPGPSGEKKLKVGFVGLDPGAPDSTRDGALLIAGSEAPKR...unknown
Potassium voltage-gated channel subfamily KQT member 4MAEAPPRRLGLGPPPGDAPRAELVALTAVQSEQGEAGGGGSPRRLGLLGS...unknown
Potassium voltage-gated channel subfamily KQT member 5MPRHHAGGEEGGAAGLWVKSGAAAAAAGGGRLGSGMKDVESGRGRVLLNS...unknown
UDP-glucuronosyltransferase 1A1MAVESQGGRPLVLGLLLCVLGPVVSHAGKILLIPVDGSHWLSMLGAIQQL...unknownsubstrate
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL41355
PubChem 121892
ChEMBL CHEMBL41355
ChEBI CHEBI:68584
CCDC/CSD YETJUF01, YETKOA, YETKEQ, YETKAM